Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

10.1182/blood-2014-07-586826

10.1182/asheducation-2011.1.110

10.1158/1078-0432.CCR-06-1183

10.1038/sj.mt.6300104

10.1200/JCO.2006.05.9964

10.1073/pnas.0813101106

10.1056/NEJMoa1103849

10.1126/scitranslmed.3002842

10.1200/JCO.2014.56.2025

10.1126/scitranslmed.3008226

10.1056/NEJMoa1407222

10.1016/S0140-6736(14)61403-3

10.1182/blood-2007-06-093906

10.1056/NEJMoa1215134

10.1182/blood-2010-04-281931

10.1016/j.immuni.2013.07.002

10.1182/blood-2007-12-128843

10.1016/j.hoc.2013.01.003

10.3324/haematol.2009.009274

Ramsay A. G., Johnson A. J., Lee A. M., Gorgün G., Le Dieu R., Blum W., Byrd J. C., Gribben J. G., Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J. Clin. Invest. 118, 2427–2437 (2008).

10.1182/blood-2014-05-552729

10.1182/blood-2013-02-485623

10.1200/JCO.2010.32.7270

10.1182/blood-2013-11-535047

10.1182/blood-2002-08-2351

10.1016/j.blre.2011.01.001

10.1038/mt.2009.83

10.1038/nbt0997-871

10.1182/blood-2003-01-0095

Levine B. L., Bernstein W. B., Connors M., Craighead N., Lindsten T., Thompson C. B., June C. H., Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159, 5921–5930 (1997).

10.1073/pnas.0608138103

10.1371/journal.pone.0057838